171 related articles for article (PubMed ID: 35085720)
1. Synthesis and bioevaluation of the cyclopentadienyl tricarbonyl technetium-99m 2-nitroimidazole derivatives for tumor hypoxia imaging.
Su H; Chu T
Bioorg Med Chem Lett; 2022 Mar; 60():128583. PubMed ID: 35085720
[TBL] [Abstract][Full Text] [Related]
2. Preparation and bioevaluation of a novel
Li S; Chu T
Bioorg Med Chem Lett; 2024 Jul; 106():129773. PubMed ID: 38677561
[TBL] [Abstract][Full Text] [Related]
3. Improving tumor/muscle and tumor/blood ratios of
Li S; Chu T
Bioorg Med Chem Lett; 2023 Feb; 82():129154. PubMed ID: 36736496
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of a new 99mTc(I)-tricarbonyl complex bearing the 5-nitroimidazol-1-yl moiety as potential hypoxia imaging agent.
Giglio J; Dematteis S; Fernández S; Cerecetto H; Rey A
J Labelled Comp Radiopharm; 2014 May; 57(6):403-9. PubMed ID: 24692093
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of [
Ruan Q; Zhang X; Gan Q; Fang S; Zhang J
Bioorg Med Chem Lett; 2020 Nov; 30(22):127582. PubMed ID: 33002601
[TBL] [Abstract][Full Text] [Related]
6. Modulation of in vivo distribution through chelator: Synthesis and evaluation of a 2-nitroimidazole-dipicolylamine-(99m)Tc(CO)3 complex for detecting tumor hypoxia.
Mallia MB; Mittal S; Sarma HD; Banerjee S
Bioorg Med Chem Lett; 2016 Jan; 26(1):46-50. PubMed ID: 26615889
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of technetium-99m-labeled propylene amine oxime complexes containing nitroimidazole and nitrotriazole groups as hypoxia markers.
Zhang Q; Huang H; Chu T
J Labelled Comp Radiopharm; 2016 Jan; 59(1):14-23. PubMed ID: 26690916
[TBL] [Abstract][Full Text] [Related]
8. Effect of a second nitroimidazole redox centre on the accumulation of a hypoxia marker: synthesis and in vitro evaluation of 99mTc-labeled bisnitroimidazole propylene amine oxime complexes.
Huang H; Zhou H; Li Z; Wang X; Chu T
Bioorg Med Chem Lett; 2012 Jan; 22(1):172-7. PubMed ID: 22153341
[TBL] [Abstract][Full Text] [Related]
9. A Novel Tumor Hypoxia Imaging Agent: [
Lin X; Tan X; Wu F; Yu Q
Curr Radiopharm; 2023; 16(4):300-307. PubMed ID: 36959152
[TBL] [Abstract][Full Text] [Related]
10. A study on nitroimidazole-99mTc(CO)3 complexes as hypoxia marker: some observations towards possible improvement in in vivo efficacy.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Banerjee S
Nucl Med Biol; 2014 Aug; 41(7):600-10. PubMed ID: 24856280
[TBL] [Abstract][Full Text] [Related]
11. On the isolation and evaluation of a novel unsubstituted 5-nitroimidazole derivative as an agent to target tumor hypoxia.
Mallia MB; Subramanian S; Mathur A; Sarma HD; Venkatesh M; Banerjee S
Bioorg Med Chem Lett; 2008 Oct; 18(19):5233-7. PubMed ID: 18774708
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of Re/
Radford LL; Papagiannopoulou D; Gallazzi F; Berendzen A; Watkinson L; Carmack T; Lewis MR; Jurisson SS; Hennkens HM
Bioorg Med Chem; 2019 Feb; 27(3):492-501. PubMed ID: 30594453
[TBL] [Abstract][Full Text] [Related]
13. Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors.
Wang X; Li D; Deuther-Conrad W; Lu J; Xie Y; Jia B; Cui M; Steinbach J; Brust P; Liu B; Jia H
J Med Chem; 2014 Aug; 57(16):7113-25. PubMed ID: 25073047
[TBL] [Abstract][Full Text] [Related]
14. Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
Fernández S; Giglio J; Rey AM; Cerecetto H
Bioorg Med Chem; 2012 Jul; 20(13):4040-8. PubMed ID: 22658538
[TBL] [Abstract][Full Text] [Related]
15. In vivo click reaction between Tc-99m-labeled azadibenzocyclooctyne-MAMA and 2-nitroimidazole-azide for tumor hypoxia targeting.
Sun W; Chu T
Bioorg Med Chem Lett; 2015 Oct; 25(20):4453-6. PubMed ID: 26358160
[TBL] [Abstract][Full Text] [Related]
16. TcO(PnA.O-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction.
Linder KE; Chan YW; Cyr JE; Malley MF; Nowotnik DP; Nunn AD
J Med Chem; 1994 Jan; 37(1):9-17. PubMed ID: 8289205
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Bioevaluation of Novel [
Yang X; Wang F; Zhu H; Yang Z; Chu T
Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298
[TBL] [Abstract][Full Text] [Related]
18.
Lin X; Ruan Q; Zhang X; Duan X; Teng Y; Zhang J
Appl Radiat Isot; 2018 Oct; 140():289-293. PubMed ID: 30092554
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and bioevaluation of radioiodinated nitroimidazole hypoxia imaging agents by one-pot click reaction.
Yang R; Wang D; Chu T
Bioorg Med Chem Lett; 2020 Sep; 30(17):127386. PubMed ID: 32738994
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological characterisation of novel dithiocarbamate containing 5-nitroimidazole (99m)Tc-complexes as potential agents for targeting hypoxia.
Giglio J; Fernández S; Rey A; Cerecetto H
Bioorg Med Chem Lett; 2011 Jan; 21(1):394-7. PubMed ID: 21087863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
